Khiron Life Sciences Stock Today
| KHRNF Stock | USD 0.0001 0.00 0.00% |
Performance12 of 100
| Odds Of DistressLess than 21
|
Khiron Life is trading at 1.0E-4 as of the 12th of December 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 1.0E-4. Khiron Life has about a 21 % chance of experiencing some form of financial distress in the next two years of operation and had a somewhat good performance during the last 90 days. The performance scores are derived for the period starting the 13th of October 2024 and ending today, the 12th of December 2024. Click here to learn more.
Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada. Khiron Life is traded on OTC Exchange in the United States. The company has 216.39 M outstanding shares. More on Khiron Life Sciences
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Khiron Pink Sheet Highlights
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Khiron Life Sciences [KHRNF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Micro-Cap' category with a current market capitalization of 17.83 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Khiron Life's market, we take the total number of its shares issued and multiply it by Khiron Life's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Khiron Life Sciences classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 216.39 M outstanding shares.
Khiron Life Sciences has accumulated about 5.82 M in cash with (20.4 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Khiron Life Probability Of Bankruptcy
Ownership AllocationKhiron Life Sciences maintains a total of 216.39 Million outstanding shares. Khiron Life Sciences secures 5.0 % of its outstanding shares held by insiders and 0.23 % owned by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Khiron Ownership Details
Khiron Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Khiron Life without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run My Watchlist Analysis Now
My Watchlist AnalysisAnalyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
| All Next | Launch Module |
Khiron Life Corporate Management
| Juan Alvarez | VP Regulations | Profile | |
| Alvaro Torres | CEO CoFounder | Profile | |
| ACA ACWA | Co Sec | Profile | |
| Helen ACA | Interim Officer | Profile | |
| Franziska Katterbach | Pres Europe | Profile | |
| Manuel Buendia | VP Operations | Profile | |
| Luis Chavez | Country Mexico | Profile |
Other Information on Investing in Khiron Pink Sheet
Khiron Life financial ratios help investors to determine whether Khiron Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Khiron with respect to the benefits of owning Khiron Life security.